Fresenius Kabi is looking for in-licensing opportunities in infusion therapy and clinical nutrition, e.g. in the area of i.v. drugs, more specifically in the areas of pain management/CNS, anesthesia, anti-infectives, inflammation and oncology. More
Helicon has identified Emergency Medicine, General and Cosmetic Surgery and Oncology markets as high potential segments in China and is seeking products with a strategic fit to the existing portfolio. More
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More
Displaying 1..10 of 18 -
per page
Next page
Order by